Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Feb 26, 2019, after the close
10-K filed Feb 26, 2019, 57 days after period end · 0001299130-19-000014
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Revenue | $19.53M | $24.94M | $25.72M | $36.28M |
| Net Income | -$30.80M | -$20.76M | -$19.03M | -$1.41M |
| EPS Diluted | — |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| — |
| — |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
